Home// - Spheroids accelerate testing anti COVID drugs
Are you sure you want to exit?
Any unsave changes will be lost.
Spheroids accelerate testing anti COVID drugs
3D Bioprinting Solutions
Category
Case Management
Country
Russia, Europe
Description
To accelerate the transition from preclinical studies with lab animals to clinical studies with humans, 3DBio scientists developed a method for the scalable production of 3D spheroids in the quantities necessary to accurately determine the specific activity of pharmacological molecules in the body of COVID-19 infected patients, thus accelerating the discovery process for anti-COVID-19 drugs.